Scaling Vision Innovation - Takeaways - MDSpire

Scaling Vision Innovation

Rob Scott, Vice President of Intraocular Devices R&D, Alcon

  • March 16, 2026

  • 3 min

Share

  • 1

    An estimated 157 million people globally suffer from uncorrected refractive errors, highlighting a significant need for eye care.

  • 2

    Alcon focuses on implantable technologies, particularly IOLs, to enhance patient outcomes through innovative research and development.

  • 3

    The PanOptix Pro IOL features a design that recovers 50% of light lost to scatter, improving visual performance based on surgeon feedback.

  • 4

    Alcon's Clareon IOL portfolio aims to address the growing demand for presbyopia-correcting IOLs as cataract surgeries are projected to reach 100 million annually by 2050.

  • 5

    Future advancements in ophthalmology will be driven by AI, robotics, and next-generation IOL technologies, aiming for clearer vision with fewer trade-offs.

Original Source(s)

Scaling Vision Innovation

  • March 16, 2026

Related Content

Refraction Pearls for the Early Presbyope

Dr. Habibi's clinical and patient counseling suggestions.

The Myopia Control Kit

Thomas Aller, OD, provides in-depth overviews of each myopia management option—pharmacologic therapy, soft contact lenses, orthokeratology, spectacle lenses, and environmental and behavioral interventions—so clinicians can not only provide the right option to each patient, but also address the larger economic and societal burdens of myopia.

Beyond the Diopter: Evolving Your Framework for Refractive Surgery Planning

Corneal health, axial length, and long-term ocular preservation are helpful guides for every refractive conversation